Shadisadat Esmaeili-Wellman
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 06, 2026
Is it "time to eliminate" time to elimination of symptoms as a primary trial endpoint for respiratory virus targeting drugs?Joshua T Schiffer, Shadisadat Esmaeili, Katherine Owens
|Jan 20, 2025
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2.Shadisadat Esmaeili, Katherine Owens, Joseph F Standing
|Jun 28, 2024
A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy.Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner
|Feb 14, 2024
A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound.Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner
|Sep 04, 2023
Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses.Katherine Owens, Shadisadat Esmaeili-Wellman, Joshua T Schiffer
|Jan 10, 2022
Noise-induced versus intrinsic oscillation in ecological systems.Shadisadat Esmaeili, Alan Hastings, Karen C Abbott
Pageof 1
